Magnetic resonance spectroscopy. Data analysis for clinical applications
暂无分享,去创建一个
Roberto Carpi | Maristella Olmastroni | Marco Esposito | Andrea Barucci | A. Ciccarrone | G. Zatelli | M. Esposito | G. Zatelli | A. Barucci | R. Carpi | M. Olmastroni | A. Ciccarrone
[1] M. van der Graaf,et al. Proton MR spectroscopy of the normal human prostate with an endorectal coil and a double spin‐echo pulse sequence , 1997, Magnetic resonance in medicine.
[2] Opstad Ks. Quantification and pattern recognition of ¹H magnetic resonance brain tumour spectra for automated classification. , 2005 .
[3] U. Klose. In vivo proton spectroscopy in presence of eddy currents , 1990, Magnetic resonance in medicine.
[4] D. Graveron-Demilly,et al. Time-domain quantitation of 1H short echo-time signals: background accommodation , 2004, Magnetic Resonance Materials in Physics, Biology and Medicine.
[5] Pravat K Mandal,et al. In vivo proton magnetic resonance spectroscopic signal processing for the absolute quantitation of brain metabolites. , 2012, European journal of radiology.
[6] T. Scheenen,et al. Reproducibility of 3D 1H MR spectroscopic imaging of the prostate at 1.5T , 2012, Journal of magnetic resonance imaging : JMRI.
[7] Denis S. Grebenkov,et al. NMR survey of reflected brownian motion , 2007 .
[8] Weili Zheng,et al. Atlas‐based automated positioning of outer volume suppression slices in short‐echo time 3D MR spectroscopic imaging of the human brain , 2011, Magnetic resonance in medicine.
[9] A H Wilman,et al. Metabolite‐specific NMR spectroscopy in vivo , 1997, NMR in biomedicine.
[10] Thomas Hambrock,et al. In vivo assessment of prostate cancer aggressiveness using magnetic resonance spectroscopic imaging at 3 T with an endorectal coil. , 2011, European urology.
[11] Olivier Tillement,et al. Gold nanoparticles designed for combining dual modality imaging and radiotherapy , 2008 .
[12] Andrew Z. Wang,et al. Nanoparticles and their applications in cell and molecular biology. , 2014, Integrative biology : quantitative biosciences from nano to macro.
[13] G M Bydder,et al. MR Imaging: Clinical Use of the Inversion Recovery Sequence , 1985, Journal of computer assisted tomography.
[14] J Hennig,et al. Coupling effects in volume selective 1H spectroscopy of major brain metabolites , 1991, Magnetic resonance in medicine.
[15] Katharina Landfester,et al. Interaction of nanoparticles with cells. , 2009, Biomacromolecules.
[16] U. Klose,et al. Reliable detection of macromolecules in single‐volume 1H NMR spectra of the human brain , 2001, Magnetic resonance in medicine.
[17] W. Perman,et al. Spatially resolved high resolution spectroscopy by “four-dimensional” NMR , 1983 .
[18] S. Provencher. Estimation of metabolite concentrations from localized in vivo proton NMR spectra , 1993, Magnetic resonance in medicine.
[19] Xavier Golay,et al. Scan time reduction in proton magnetic resonance spectroscopic imaging of the human brain , 2001, Magnetic Resonance in Medicine.
[20] Cosimo Trono,et al. Intracellular delivery of molecular beacons by PMMA nanoparticles and carbon nanotubes for mRNA sensing , 2013, Photonics West - Biomedical Optics.
[21] H. Hricak,et al. Detection of prostate cancer with MR spectroscopic imaging: an expanded paradigm incorporating polyamines. , 2007, Radiology.
[22] Ricardo Otazo,et al. MR spectroscopic imaging: Principles and recent advances , 2013, Journal of magnetic resonance imaging : JMRI.
[23] R. Franklin,et al. Citrate metabolism of normal and malignant prostate epithelial cells. , 1997, Urology.
[24] A. O. Rodríguez,et al. Principles of magnetic resonance imaging , 2004 .
[25] A. A. Maudsley,et al. Reproducibility of serial whole‐brain MR Spectroscopic Imaging , 2009, NMR in biomedicine.
[26] J. Karp,et al. Nanocarriers as an Emerging Platform for Cancer Therapy , 2022 .
[27] P. Bottomley. Spatial Localization in NMR Spectroscopy in Vivo , 1987, Annals of the New York Academy of Sciences.
[28] P Boesiger,et al. Pitfalls in lactate measurements at 3T. , 2006, AJNR. American journal of neuroradiology.
[29] Luciano Merlini,et al. Cationic PMMA nanoparticles bind and deliver antisense oligoribonucleotides allowing restoration of dystrophin expression in the mdx mouse. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.
[30] Lev Dykman,et al. Biodistribution and toxicity of engineered gold nanoparticles: a review of in vitro and in vivo studies. , 2011, Chemical Society reviews.
[31] B. Mueller,et al. Proton echo‐planar spectroscopic imaging of J‐coupled resonances in human brain at 3 and 4 Tesla , 2007, Magnetic resonance in medicine.
[32] C Boesch,et al. Versatile frequency domain fitting using time domain models and prior knowledge , 1998, Magnetic resonance in medicine.
[33] Michael Garwood,et al. Solvent Suppression Using Selective Echo Dephasing , 1996 .
[34] J. Pauly,et al. Design of symmetric‐sweep spectral‐spatial RF pulses for spectral editing , 2004, Magnetic resonance in medicine.
[35] P F Renshaw,et al. In vivo detection of GABA in human brain using a localized double‐quantum filter technique , 1997, Magnetic resonance in medicine.
[36] John Kurhanewicz,et al. Quantification of prostate MRSI data by model‐based time domain fitting and frequency domain analysis , 2006, NMR in biomedicine.
[37] P. Sundgren,et al. Diffusion tensor imaging of the brain: review of clinical applications , 2004, Neuroradiology.
[38] D. C. Soares,et al. Theranostic Nanoparticles: Imaging and Therapy Combined , 2014 .
[39] T. Scheenen,et al. Prostate MRI and 3D MR spectroscopy: how we do it. , 2010, AJR. American journal of roentgenology.
[40] W S Ng,et al. Endorectal magnetic resonance imaging and spectroscopy for the detection of tumor foci in men with prior negative transrectal ultrasound prostate biopsy. , 2004, The Journal of urology.
[41] T. Scheenen,et al. Role of high‐field MR in studies of localized prostate cancer , 2014, NMR in biomedicine.
[42] Oded Gonen,et al. Metabolite ratios to assumed stable creatine level may confound the quantification of proton brain MR spectroscopy. , 2003, Magnetic resonance imaging.
[43] Olivier Scheidegger,et al. Optimized quantitative magnetic resonance spectroscopy for clinical routine , 2013, Magnetic resonance in medicine.
[44] Andrew G. Webb,et al. Parallel transmit and receive technology in high‐field magnetic resonance neuroimaging , 2010, Int. J. Imaging Syst. Technol..
[45] S. Mori,et al. Principles of Diffusion Tensor Imaging and Its Applications to Basic Neuroscience Research , 2006, Neuron.
[46] J. Kurhanewicz,et al. Improved water and lipid suppression for 3D PRESS CSI using rf band selective inversion with gradient dephasing (basing) , 1997, Magnetic resonance in medicine.
[47] Olivier Beuf,et al. Design of Gold Nanoparticles for Magnetic Resonance Imaging , 2006 .
[48] Vladimir Torchilin,et al. Tumor delivery of macromolecular drugs based on the EPR effect. , 2011, Advanced drug delivery reviews.
[49] K. Uğurbil,et al. NMR chemical shift imaging in three dimensions. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[50] M. Spraul,et al. Ultra high field NMR spectroscopic studies on human seminal fluid, seminal vesicle and prostatic secretions. , 1994, Journal of pharmaceutical and biomedical analysis.
[51] D P Auer,et al. On the reliability of quantitative clinical magnetic resonance spectroscopy of the human brain , 1995, NMR in biomedicine.
[52] Lin Mei,et al. Nanotheranostics ˗ Application and Further Development of Nanomedicine Strategies for Advanced Theranostics , 2014, Theranostics.
[53] A. Heerschap,et al. Removal of the outer lines of the citrate multiplet in proton magnetic resonance spectra of the prostatic gland by accurate timing of a point-resolved spectroscopy pulse sequence , 1997, Magnetic Resonance Materials in Physics, Biology and Medicine.
[54] T. Scheenen,et al. In vivo 1H MR spectroscopic imaging of aggressive prostate cancer: Can we detect lactate? , 2014, Magnetic resonance in medicine.
[55] Geoffrey D Clarke,et al. Proton magnetic resonance spectroscopy in the brain: report of AAPM MR Task Group #9. , 2002, Medical physics.
[56] Abass Alavi,et al. Emerging role of radiolabeled nanoparticles as an effective diagnostic technique , 2012, EJNMMI Research.
[57] R. Schipper,et al. Polyamines and prostatic cancer. , 2003, Biochemical Society transactions.
[58] Michael Garwood,et al. Sequence design for magnetic resonance spectroscopic imaging of prostate cancer at 3 T , 2005, Magnetic resonance in medicine.
[59] P. Carroll,et al. Prostate depiction at endorectal MR spectroscopic imaging: investigation of a standardized evaluation system. , 2004, Radiology.
[60] Tingxian Liu,et al. Multifunctional pH-sensitive polymeric nanoparticles for theranostics evaluated experimentally in cancer. , 2014, Nanoscale.
[61] Francis Vocanson,et al. Gadolinium chelate coated gold nanoparticles as contrast agents for both X-ray computed tomography and magnetic resonance imaging. , 2008, Journal of the American Chemical Society.
[62] Guo-Feng Luo,et al. Therapeutic nanomedicine based on dual-intelligent functionalized gold nanoparticles for cancer imaging and therapy in vivo. , 2013, Biomaterials.
[63] B J Soher,et al. Quantitation of automated single‐voxel proton MRS using cerebral water as an internal reference , 1996, Magnetic resonance in medicine.
[64] H. Huisman,et al. Standardized Threshold Approach Using Three-Dimensional Proton Magnetic Resonance Spectroscopic Imaging in Prostate Cancer Localization of the Entire Prostate , 2007, Investigative radiology.
[65] van der Graaf M,et al. Effect of Cation Binding on the Proton Chemical Shifts and the Spin-Spin Coupling Constant of Citrate , 1996, Journal of magnetic resonance. Series B.
[66] C. Picu,et al. NMR relaxation and pulsed-gradient diffusion study of polyethylene nanocomposites. , 2005, The Journal of chemical physics.
[67] Hui Mao,et al. Improving the Magnetic Resonance Imaging Contrast and Detection Methods with Engineered Magnetic Nanoparticles , 2012, Theranostics.
[68] L. Sillerud,et al. The pH dependence of chemical shift and spin-spin coupling for citrate. , 1994, Journal of magnetic resonance. Series B.
[69] D. I. Hoult,et al. Critical factors in the design of sensitive high resolution nuclear magnetic resonance spectrometers , 1975, Proceedings of the Royal Society of London. A. Mathematical and Physical Sciences.
[70] Teri W. Odom,et al. High relaxivity Gd(III)-DNA gold nanostars: investigation of shape effects on proton relaxation. , 2015, ACS nano.
[71] M. van der Graaf,et al. Human prostate: multisection proton MR spectroscopic imaging with a single spin-echo sequence--preliminary experience. , 1999, Radiology.
[72] M. Sdika,et al. Time‐domain semi‐parametric estimation based on a metabolite basis set , 2005, NMR in biomedicine.
[73] M. van der Graaf,et al. Echo-time independent signal modulations using PRESS sequences: a new approach to spectral editing of strongly coupled AB spin systems. , 2005, Journal of magnetic resonance.
[74] Idriss Blakey,et al. Multimodal polymer nanoparticles with combined 19F magnetic resonance and optical detection for tunable, targeted, multimodal imaging in vivo. , 2014, Journal of the American Chemical Society.
[75] P. Allen,et al. Response of metabolites with coupled spins to the STEAM sequence , 2001, Magnetic resonance in medicine.
[76] Roberto Passariello,et al. Value of Magnetic Resonance Spectroscopy Imaging and Dynamic Contrast-Enhanced Imaging for Detecting Prostate Cancer Foci in Men With Prior Negative Biopsy , 2010, Clinical Cancer Research.
[77] T. Scheenen,et al. Three-dimensional proton MR spectroscopy of human prostate at 3 T without endorectal coil: feasibility. , 2007, Radiology.
[78] A. Wilman,et al. The response of the strongly coupled AB system of citrate to typical 1H MRS localization sequences. , 1995, Journal of magnetic resonance. Series B.
[79] J. Kurhanewicz,et al. 1H MR spectroscopy of normal and malignant human prostates in Vivo , 1990 .
[80] D. Hirst,et al. Gold nanoparticles as novel agents for cancer therapy. , 2012, The British journal of radiology.
[81] P. Carroll,et al. Quantification of choline‐ and ethanolamine‐containing metabolites in human prostate tissues using 1H HR‐MAS total correlation spectroscopy , 2008, Magnetic resonance in medicine.
[82] K. Kuroda,et al. A precise and fast temperature mapping using water proton chemical shift , 1995, Magnetic resonance in medicine.
[83] J Star-Lack,et al. High spatial resolution 1H‐MRSI and segmented MRI of cortical gray matter and subcortical white matter in three regions of the human brain , 1999, Magnetic resonance in medicine.
[84] Michael B. Smith,et al. Central brightening due to constructive interference with, without, and despite dielectric resonance , 2005, Journal of magnetic resonance imaging : JMRI.
[85] F. Baldini,et al. Human dermal fibroblasts HDFa can be used as an appropriate healthy control for PMMA nanoparticles-survivin molecular beacon cellular uptake studies. , 2015, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[86] P. Jain,et al. Gold nanoparticles: interesting optical properties and recent applications in cancer diagnostics and therapy. , 2007, Nanomedicine.
[87] Cosimo Trono,et al. Complex Nanostructures Based on Oligonucleotide Optical Switches and Nanoparticles for Intracellular mRNA Sensing and Silencing , 2014 .
[88] S. Provencher. Automatic quantitation of localized in vivo 1H spectra with LCModel , 2001, NMR in biomedicine.
[89] D. Leibfritz,et al. A 1H/13C inverse 2D method for the analysis of the polyamines putrescine, spermidine and spermine in cell extracts and biofluids , 1998, NMR in biomedicine.
[90] Roberto Pini,et al. Gold Nanoparticles : Engineering Photothermal effects in connective tissues mediated by laser-activated gold nanorods , 2009 .
[91] Vanhamme,et al. Improved method for accurate and efficient quantification of MRS data with use of prior knowledge , 1997, Journal of magnetic resonance.
[92] Brian D. Ross,et al. Magnetic Resonance Spectroscopy Diagnosis of Neurological Diseases , 1999 .
[93] M. Zerbib,et al. Negative prostatic biopsies in patients with a high risk of prostate cancer. Is the combination of endorectal MRI and magnetic resonance spectroscopy imaging (MRSI) a useful tool? A preliminary study. , 2005, European urology.
[94] F. Schick,et al. Localized proton MR spectroscopy of citrate in vitro and of the human prostate in vivo at 1.5 T , 1993, Magnetic resonance in medicine.
[95] B. Tomanek,et al. Applications of nanoparticles for MRI cancer diagnosis and therapy , 2013 .
[96] Chrit T. W. Moonen,et al. Highly Effective Water Suppression for in vivo proton NMR Spectroscopy (DRYSTEAM) , 1990 .
[97] Gioacchino Tedeschi,et al. High Speed 1H Spectroscopic Imaging in Human Brain by Echo Planar Spatial‐Spectral Encoding , 1995, Magnetic resonance in medicine.
[98] R. Gruetter,et al. In vivo 1H NMR spectroscopy of rat brain at 1 ms echo time , 1999, Magnetic resonance in medicine.
[99] P. Carroll,et al. Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution. , 1996, Radiology.
[100] W.M.M.J. Bovée,et al. A single-shot localization pulse sequence suited for coils with inhomogeneous RF fields using adiabatic slice-selective RF pulses , 1991 .
[101] M. Wyss,et al. Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the 'phosphocreatine circuit' for cellular energy homeostasis. , 1992, The Biochemical journal.
[102] P. Carroll,et al. Quantitative analysis of prostate metabolites using 1H HR‐MAS spectroscopy , 2006, Magnetic resonance in medicine.
[103] Klaas Nicolay,et al. 1H MR spectroscopy of the brain: absolute quantification of metabolites. , 2006, Radiology.
[104] B J Soher,et al. Quantitation of proton NMR spectra of the human brain using tissue water as an internal concentration reference , 1993, NMR in biomedicine.
[105] L. R. Jensen,et al. Peripheral Zone Prostate Cancer Localization by Multiparametric Magnetic Resonance at 3 T: Unbiased Cancer Identification by Matching to Histopathology , 2012, Investigative radiology.
[106] Taeghwan Hyeon,et al. Designed fabrication of multifunctional magnetic gold nanoshells and their application to magnetic resonance imaging and photothermal therapy. , 2006, Angewandte Chemie.
[107] D. Graveron-Demilly,et al. Java-based graphical user interface for the MRUI quantitation package , 2001, Magnetic Resonance Materials in Physics, Biology and Medicine.
[108] J H Duyn,et al. Multisection proton MR spectroscopic imaging of the brain. , 1993, Radiology.
[109] A. C. Hunter,et al. Nanomedicine: current status and future prospects , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[110] Hao Hong,et al. Molecular imaging and therapy of cancer with radiolabeled nanoparticles. , 2009, Nano today.
[111] P. López-Larrubia,et al. Quantitative 1H MR spectroscopic imaging of the prostate gland using LCModel and a dedicated basis‐set: Correlation with histologic findings , 2011, Magnetic resonance in medicine.
[112] Jens Frahm,et al. Regional Age Dependence of Human Brain Metabolites from Infancy to Adulthood as Detected by Quantitative Localized Proton MRS , 1999, Pediatric Research.
[113] R. Gruetter,et al. Echo-time independent signal modulations for strongly coupled systems in triple echo localization schemes: an extension of S-PRESS editing. , 2010, Journal of magnetic resonance.
[114] M. Kattan,et al. Correlation of proton MR spectroscopic imaging with gleason score based on step-section pathologic analysis after radical prostatectomy. , 2005, Radiology.
[115] P. Carroll,et al. Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging--clinicopathologic study. , 1999, Radiology.
[116] M. Moseley,et al. In vivo MR tractography using diffusion imaging. , 2003, European journal of radiology.
[117] B. Choe,et al. Theoretical Evaluation of Magnetization Behavior in PRESS: for Determination of the Spin-Lattice Relaxation Time, T1 , 2002 .
[118] C Boesch,et al. Brain metabolite composition during early human brain development as measured by quantitative in vivo 1H magnetic resonance spectroscopy , 2002, Magnetic resonance in medicine.
[119] Sabine Van Huffel,et al. An automated quantitation of short echo time MRS spectra in an open source software environment: AQSES , 2007, NMR in biomedicine.
[120] Roger J. Ordidge,et al. Image-selected in Vivo spectroscopy (ISIS). A new technique for spatially selective nmr spectroscopy , 1986 .
[121] J. Frahm,et al. Absolute concentrations of metabolites in the adult human brain in vivo: quantification of localized proton MR spectra. , 1993, Radiology.
[122] A. Macovski,et al. Volumetric spectroscopic imaging with spiral‐based k‐space trajectories , 1998, Magnetic resonance in medicine.
[123] Steren Chabert,et al. Diffusion signal in magnetic resonance imaging: origin and interpretation in neurosciences. , 2007, Biological research.
[124] O Henriksen,et al. In vivo quantification of brain metabolites by 1H-MRS using water as an internal standard. , 1993, Magnetic resonance imaging.
[125] G. Sotgiu,et al. Sulfonates-PMMA nanoparticles conjugates: a versatile system for multimodal application. , 2012, Bioorganic & medicinal chemistry.
[126] M. Ratner,et al. Size dependence of ferromagnetism in gold nanoparticles: Mean field results , 2007 .
[127] H. Hricak,et al. Clinical application of BASING and spectral/spatial water and lipid suppression pulses for prostate cancer staging and localization by in vivo 3D 1H magnetic resonance spectroscopic imaging , 2000, Magnetic resonance in medicine.
[128] C Gabriel,et al. The dielectric properties of biological tissues: I. Literature survey. , 1996, Physics in medicine and biology.
[129] Y. Assaraf,et al. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance. , 2011, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[130] Zenon Starčuk,et al. Quantitation of magnetic resonance spectroscopy signals: the jMRUI software package , 2009 .
[131] Roberto Pini,et al. Size and shape control in the overgrowth of gold nanorods , 2010 .
[132] S. Blackband,et al. Quantification of citrate concentration in the prostate by proton magnetic resonance spectroscopy: Zonal and age‐related differences , 1996, Magnetic resonance in medicine.
[133] Douglas L. Rothman,et al. In vivo detection and quantification of scalar coupled H NMR resonances , 2001 .
[134] Katarzyna J Macura,et al. Prostate cancer: sextant localization at MR imaging and MR spectroscopic imaging before prostatectomy--results of ACRIN prospective multi-institutional clinicopathologic study. , 2009, Radiology.
[135] J. Pauly,et al. Dualband spectral‐spatial RF pulses for prostate MR spectroscopic imaging , 2001, Magnetic resonance in medicine.
[136] Dennis W J Klomp,et al. Optimal timing for in vivo 1H‐MR spectroscopic imaging of the human prostate at 3T , 2005, Magnetic resonance in medicine.
[137] M W Weiner,et al. Region and tissue differences of metabolites in normally aged brain using multislice 1H magnetic resonance spectroscopic imaging , 2001, Magnetic resonance in medicine.
[138] JeremyK. Nicholson,et al. Proton MRS of human prostatic fluid: Correlations between citrate, spermine, and myo‐inositol levels and changes with disease , 1997, The Prostate.
[139] Cosimo Trono,et al. Polymethylmethacrylate nanoparticles as carrier of an oligodeoxynucleotide molecular beacon specific for survivin mRNA in A549 human lung adenocarcinoma epithelial cells , 2015, 2015 XVIII AISEM Annual Conference.
[140] N. deSouza,et al. The effect of experimental conditions on the detection of spermine in cell extracts and tissues , 2009, NMR in biomedicine.
[141] H. Lei,et al. Simultaneous spectral editing for gamma-aminobutyric acid and taurine using double quantum coherence transfer. , 2000, Journal of magnetic resonance.
[142] Don Haeng Lee,et al. Photo-cured PMMA/PEI core/shell nanoparticles surface-modified with Gd-DTPA for T1 MR imaging. , 2014, Journal of colloid and interface science.
[143] P. Boesiger,et al. Optimizing PRESS localized citrate detection at 3 Tesla , 2005, Magnetic resonance in medicine.
[144] Yunpeng Huang,et al. Multifunctional dendrimer-entrapped gold nanoparticles for dual mode CT/MR imaging applications. , 2013, Biomaterials.
[145] Z L Gokaslan,et al. Limitations of stereotactic biopsy in the initial management of gliomas. , 2001, Neuro-oncology.
[146] Jeong Yu Lee,et al. Optically Traceable Solid Lipid Nanoparticles Loaded with siRNA and Paclitaxel for Synergistic Chemotherapy with In situ Imaging , 2013, Advanced healthcare materials.
[147] J. Hennig,et al. Improved sensitivity to overlapping multiplet signals in in vivo proton spectroscopy using a multiecho volume selective (CPRESS) experiment , 1997, Magnetic resonance in medicine.
[148] Ji-Xin Cheng,et al. Hyperthermic effects of gold nanorods on tumor cells. , 2007, Nanomedicine.
[149] B D Ross,et al. Absolute Quantitation of Water and Metabolites in the Human Brain. I. Compartments and Water , 1993 .
[150] R. Bammer. Basic principles of diffusion-weighted imaging. , 2003, European journal of radiology.
[151] Mingwu Shen,et al. Multifunctional dendrimer-entrapped gold nanoparticles modified with RGD peptide for targeted computed tomography/magnetic resonance dual-modal imaging of tumors. , 2015, Analytical chemistry.
[152] J Kurhanewicz,et al. Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone: detection via localized proton spectroscopy. , 1995, Urology.
[153] Ad Bax,et al. Improved solvent suppression in one-and two-dimensional NMR spectra by convolution of time-domain data , 1989 .
[154] B. Meier,et al. Computer Simulations in Magnetic Resonance. An Object-Oriented Programming Approach , 1994 .
[155] H. Ahn,et al. Stromal cells of the human prostate: Initial isolation and characterization , 1996, The Prostate.
[156] V. Zharov,et al. Photothermal nanodrugs: potential of TNF-gold nanospheres for cancer theranostics , 2013, Scientific Reports.
[157] Heinz-Peter Schlemmer,et al. Discriminating Cancer From Noncancer Tissue in the Prostate by 3-Dimensional Proton Magnetic Resonance Spectroscopic Imaging: A Prospective Multicenter Validation Study , 2011, Investigative radiology.
[158] P. Allen,et al. Sources of variability in the response of coupled spins to the PRESS sequence and their potential impact on metabolite quantification , 1999, Magnetic resonance in medicine.
[159] T. Scheenen,et al. Mapping of prostate cancer by 1H MRSI , 2014, NMR in biomedicine.
[160] V. Govindaraju,et al. Proton NMR chemical shifts and coupling constants for brain metabolites , 2000, NMR in biomedicine.
[161] E Lucarelli,et al. Mesenchymal stem cells as delivery vehicle of porphyrin loaded nanoparticles: effective photoinduced in vitro killing of osteosarcoma. , 2013, Journal of controlled release : official journal of the Controlled Release Society.
[162] P. Barker,et al. Diffusion magnetic resonance imaging: Its principle and applications , 1999, The Anatomical record.